Atb Cap Markets Forecasts Organigram Q1 Earnings

Organigram Holdings Inc. (NASDAQ:OGI) – Equities researchers at Atb Cap Markets issued their Q1 2025 earnings estimates for Organigram in a research report issued on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes expects that the company will earn ($0.02) per share for the quarter. The consensus estimate for Organigram’s current full-year earnings is ($0.20) per share. Atb Cap Markets also issued estimates for Organigram’s Q2 2025 earnings at ($0.03) EPS and FY2025 earnings at ($0.07) EPS.

Organigram Price Performance

NASDAQ OGI opened at $1.56 on Monday. The business’s 50-day simple moving average is $1.61 and its 200-day simple moving average is $1.67. The firm has a market capitalization of $196.80 million, a P/E ratio of -3.71 and a beta of 1.02. Organigram has a 1-year low of $1.25 and a 1-year high of $2.91.

Organigram (NASDAQ:OGI) last issued its earnings results on Wednesday, December 18th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.01). Organigram had a negative return on equity of 16.76% and a negative net margin of 45.57%.

Institutional Investors Weigh In On Organigram

Several institutional investors have recently bought and sold shares of the business. Tidal Investments LLC lifted its holdings in shares of Organigram by 8.3% during the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock valued at $3,526,000 after acquiring an additional 149,171 shares in the last quarter. Toronto Dominion Bank raised its position in Organigram by 803.7% in the third quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock valued at $30,000 after purchasing an additional 14,876 shares during the period. Renaissance Technologies LLC lifted its stake in shares of Organigram by 40.8% during the second quarter. Renaissance Technologies LLC now owns 816,948 shares of the company’s stock worth $1,258,000 after purchasing an additional 236,700 shares in the last quarter. Finally, AdvisorShares Investments LLC boosted its position in shares of Organigram by 11.8% in the second quarter. AdvisorShares Investments LLC now owns 1,000,126 shares of the company’s stock worth $1,540,000 after buying an additional 105,468 shares during the period. 34.63% of the stock is currently owned by hedge funds and other institutional investors.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.